Back to Search
Start Over
Supplemental figure 3 from Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplemental figure 3: SERDs and palbociclib inhibit breast cancer cell proliferation by independent mechanisms
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....913466b83847b02760d8832503645b8d
- Full Text :
- https://doi.org/10.1158/1078-0432.22454691.v1